Samsung Biologics named John Rim as its president and CEO effectively immediately. Since 2018, he has served as executive vice president at Samsung Biologics. Previously Rim worked for Genentech/Roche in a variety of senior global leadership roles. He also served in leadership roles at Astellas Pharma.